Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
BioAtla, Inc. Banner

BioAtla, Inc.

BCAB Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Net Income
-28.979m-29.855m-35.853m-95.402m-106.482m-123.462m
Depreciation & Amortization
794.000K860.000K1.008M1.330M1.199M1.221M
Change in Working Capital
-9.704m25.102M-2.498m7.424M287.000K4.680M
Operating Cash Flow
-35.317m-9.645m-36.334m-62.214m-90.420m-104.015m
Capital Expenditure
-988.000k-1.509m-590.000k-924.000k-268.000k-98.000k
Free Cash Flow
-36.305m-11.154m-36.924m-63.138m-90.688m-104.113m
Debt Repayment
-5.000m-4.000m-3.432m0.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.000
Common Stock Issued
0.0000.000200.229M71.423M61.971M336.000K
Common Stock Repurchased
0.0000.0000.0000.000-758.000-259.000
Net Change in Cash
-31.286m-7.159m234.901M6.374M-29.472m-104.036m